ࡱ> }| sbjbj_W_W 4====jGpp@@@@@TTT8TTC$:......&C(C(C(C(C(C(C,DGrTC@.....TCn@@..iCnnn.R@.@.&Cn.&Cnn.AlBPNB*CC0CB*GnGTBn@B$...TCTCn...CG.........p :   LICENSE AGREEMENT PREAMBLE This Agreement is made and entered into to be effective the ____ day of ____________, 20__, by and between the UNIVERSITY OF AKRON RESEARCH FOUNDATION, a corporation not for profit under Section 17 O.R.C., and a support organization of ɫƵ (ɫƵ) having its principal office at 170 University Circle, Akron OH 44325-2103, U.S.A. (hereinafter referred to as RESEARCH FOUNDATION), and ___________________________________, a corporation duly organized under the laws of the State of ________________________and having its principal office at ________________________________________________________________(hereinafter referred to as LICENSEE). WITNESSETH WHEREAS, RESEARCH FOUNDATION is the exclusive licensee under certain Patent Rights (as later defined herein) relating to _______________________________________________________________________________and has the right to grant licenses under said Patent Rights; WHEREAS, RESEARCH FOUNDATION desires to have the Patent Rights utilized in the public interest and is willing to grant a license thereunder; and WHEREAS, LICENSEE intends to develop, produce, manufacture, market and/or sell products similar to the Licensed Product(s) (as later defined herein) and is willing to commit itself to a diligent program of exploiting the Patent Rights so that public utilization shall result therefrom; and WHEREAS, LICENSEE desires to obtain a license under the Patent Rights upon the terms and conditions hereinafter set forth. NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, the parties hereto agree as follows: ARTICLE I. DEFINITIONS For the purposes of this Agreement, the following words and phrases shall have the following meanings: LICENSEE shall include: a related company of LICENSEE, the voting stock of which is, directly or indirectly, at least fifty percent (50%) owned or controlled by LICENSEE; an organization which directly or indirectly controls more than fifty percent (50%) of the voting stock of LICENSEE; and an organization, the majority ownership of which is, directly or indirectly, common to the ownership of LICENSEE. Patent Rights shall mean the Patent Applications listed in Appendix A hereto and any patent issued from said applications and from divisionals and continuations of said applications; and any corresponding applications or patents issuing thereon in the Territory as defined in Article 1.7. Technology shall mean the ___________________________________________________disclosed in the Patent Rights and know how related directly thereto. A Licensed Process shall mean any process that is based upon, covered by or utilizes the Technology in any relevant respect. A Licensed Product shall mean any product or part of thereof which is based upon, covered by or utilizes the Technology or is made by a Licensed Process. Net Sales shall mean LICENSEEs and its sublicensees billings for Licensed Products sold or leased hereunder less the sum of the following: discounts allowed in amounts customary in the trade; sales, tariff duties and/or use taxes directly imposed and with reference to particular sales; outbound transportation prepaid or allowed; and amounts allowed or credited on returns. No deductions shall be made for commissions paid to individuals whether they are with independent sales agencies or regularly employed by LICENSEE and on its payroll, or for cost of collections. Licensed Products shall be considered sold or leased when used, billed out or invoiced. If the Licensed Product is used by, sold or leased to a related person or is leased or exchanged for a consideration other than money, billings shall be the gross selling price of comparable Licensed Products sold in arms length transactions by Licensee or, if no sales or leases of comparable Licensed Products have been made, then the fair market value there of. Territory shall mean _________________________________________________________________. 1.8. Field shall mean ____________________________________________________________________. ARTICLE II. GRANT RESEARCH FOUNDATION hereby grants to LICENSEE the exclusive right and license in the Territory to make, have made, use, sublicense, lease and sell the Licensed Products for use in the Field, and to practice and to sublicense the Licensed Processes in the Field to the end of the term for which the Patent Rights are granted unless sooner terminated according to the terms hereof. In addition, Research Foundation hereby grants Licensee an option to acquire a license in ɫƵ patents to the extent such rights can be granted and only to the extent necessary for LICENSEE to avoid infringement of such patents in LICENSEEs practice of Licensed Processes and Licensed Products granted under this Article 2.1. RESEARCH FOUNDATION reserves to ɫƵ the right to use the Technology and to practice under the Patent Rights for ɫƵs noncommercial research and education purposes. The license granted hereunder shall not be construed to confer any rights upon LICENSEE by implication, estoppel or otherwise as to any technology except as specifically set forth herein. LICENSEE agrees that any sublicenses granted by it shall contain such provisions as are necessary for LICENSEE to meet its obligations under this Agreement and to reasonably protect the interests of RESEARCH FOUNDATION with regard to such sublicense. LICENSEE agrees to forward to RESEARCH FOUNDATION a copy of any and all fully executed sublicense agreements for Licensed Products or Licensed Processes and further agrees to forward to RESEARCH FOUNDATION annually a copy of such reports received by LICENSEE from its sublicensees during the preceding twelve (12) month period under the sublicenses as shall be pertinent to a royalty accounting under said sublicense agreements. LICENSEE shall report to RESEARCH FOUNDATION within thirty (30) days after receiving from sublicensees anything of value in lieu of cash payments in consideration for any sublicense under this Agreement, which consideration shall be subject to the express written approval of RESEARCH FOUNDATION. Termination under any of the provisions of this Agreement of the license granted to LICENSEE in this Agreement shall terminate all sublicenses which may have been granted by LICENSEE, provided that any sublicensee may elect to continue its sublicense by advising Research Foundation in writing, within (60) sixty days of the sublicensees receipt of written notice of such termination, of its election and of its agreement to assume in respect to Research Foundation all the obligations (including obligations for payment) contained in its sublicensing agreement with LICENSEE. Any sublicense granted by LICENSEE shall contain provisions corresponding to those of this paragraph respecting termination and the conditions of continuance of sublicenses. ARTICLE III. DUE DILIGENCE 3.1. LICENSEE shall use its best efforts to bring one or more Licensed Products or Licensed Processes to market with respect to each of the Patent Rights listed on Appendix A or acquired pursuant to LICENSEEs exercise of its option under Article 2.1, through a diligent program for exploitation of the Patent Rights, and LICENSEEs failure to so perform shall be grounds for RESEARCH FOUNDATION to terminate this Agreement pursuant to Paragraph 13.3. hereof. Failure to bring at least one Licensed Product or Licensed Process to successful commercialization by ________________________, shall be considered to be a default under Paragraph 13.3 hereof. ARTICLE IV. ROYALTIES and FEES For the rights, privileges and license granted hereunder, LICENSEE shall pay fees and royalties to RESEARCH FOUNDATION in the manner hereinafter provided to the end of the term of the Patent Rights or until this Agreement shall be terminated as hereinafter provided: A License fee of that number of shares of each class of LICENSEEs stock as will amount to not less than ___ percent (__%) of the total authorized shares for each class; and such additional number of shares from time-to-time as may be necessary for RESEARCH FOUNDATION to maintain at all times at least a ___ percent (__%) ownership stake and share in LICENSEE. Registration and transfer rights for such shares shall be no less favorable than that afforded other insiders, and shall piggyback on initial or, with respect to additional shares, the next, LICENSEE registrations. The License fee shall be deemed earned and due immediately upon the execution of this Agreement. Beginning January 1, 20__, Running Royalties equal to _____ percent (__%) of Net Sales of the Licensed Products and Licensed Processes made, used, leased or sold by or for LICENSEE. Beginning January 1, 20__, Running Royalties equal to _____ percent (__%) of Net Sales of the Licensed Products and Licensed Processes made, used, leased or sold by or for LICENSEE. Minimum Royalties of ____ Thousand Dollars ($__0,000) for the year 20__ are payable March 31, 20__. Minimum Royalties of ______ Thousand Dollars ($__0,000) for the year 20___ are payable March 31, 20__. Minimum Royalties of ______ Thousand Dollars ($__0,000) for the year 2007 are payable March 31, 20__, and each March 31st thereafter for the immediately preceding year. LICENSEE may offset Running Royalties earned and paid in any calendar year against the Minimum Royalty payable for that year. Fifty percent (50%) of all License Fees received by LICENSEE from any sublicensee. As used in the preceding sentence, the term License Fees means fees, consideration or anything else of value received by LICENSEE for license of rights to the Licensed Products, Patent Rights, and Licensed Processes, excluding Royalties paid to LICENSEE with respect to sublicensees Net Sales. Royalty and Fee payments shall be paid in United States dollars in Akron, Ohio or at such other place as RESEARCH FOUNDATION may reasonably designate consistent with the laws and regulations controlling in any foreign country. If any currency conversion shall be required in connection with the payment of Royalties or Fees hereunder, such conversion shall be made by using the exchange rate prevailing at the Chase Manhattan Bank (N.A.) on the last business day of the calendar semi-annual reporting period to which such royalty payments relate. ARTICLE V. REPORTS AND RECORDS LICENSEE shall keep full, true and accurate books of account containing all particulars that may be necessary for the purpose of showing the amounts payable to RESEARCH FOUNDATION hereunder, and said books and the supporting data shall be open at all reasonable times for five (5) years following the end of the calendar year to which they pertain, to the inspection of RESEARCH FOUNDATION or its agents for the purpose of verifying LICENSEEs Royalty and Fee statement or compliance in other respects with this Agreement. LICENSEE, within sixty (60) days after June 30, and December 31, of each year, shall deliver to RESEARCH FOUNDATION true and accurate reports, giving such particulars of the business conducted by LICENSEE and its sublicensees during the preceding six-month period under this Agreement as shall be pertinent to a royalty accounting hereunder, including an accounting for Licensed Processes used and Licensed Products and the billings, deductions and royalties due with respect thereto. With each such report submitted, LICENSEE shall pay to RESEARCH FOUNDATION the Royalties and Fees due and payable under this Agreement. If no Royalties or Fees shall be due, LICENSEE shall so report. The payments set forth in this Agreement shall, if overdue, bear interest until payment at a per annum rate of the prime rate as reported by Chase Manhattan Bank, N.A. plus four percent (4%). The payment of such interest shall not foreclose RESEARCH FOUNDATION from exercising any other rights it may have as a consequence of the lateness of the payment. ARTICLE VI. PATENT PROSECUTION RESEARCH FOUNDATION shall be responsible for and ensure the prompt issuance of the Patent Rights and that such Patent Rights shall be maintained during the term of this Agreement in the Territory. RESEARCH FOUNDATION shall also be responsible for obtaining such other available Patent Rights protection as LICENSEE may request at LICENSEEs sole expense. LICENSEE shall reimburse RESEARCH FOUNDATION for past costs incurred by RESEARCH FOUNDATION and ɫƵ with respect to all Patent Rights in the Territory, to be paid in full within 30 days of the effective date of this Agreement and thereafter as such costs are incurred. If LICENSEE declines to seek protection in any country in the Territory, or shall at any time decide to discontinue prosecution or maintenance of any patent or patent application filed in any country in the Territory, LICENSEE agrees to give RESEARCH FOUNDATION a minimum of thirty (30) days notice. RESEARCH FOUNDATION at its sole discretion and expense, reserves the right to file, issue and/or maintain such patent applications and patents and LICENSEE will have no further rights with respect thereto. ARTICLE VII. INFRINGEMENT The parties shall inform each other promptly, in writing, of any alleged infringement of the Patent Rights by a third party, and any available evidence thereof. During the term of this Agreement, LICENSEE shall have the right, subject only to approval not unreasonably withheld of RESEARCH FOUNDATION, but shall not be obligated to prosecute at its own expense any such infringements of the Patent Rights and, in furtherance of such right, RESEARCH FOUNDATION hereby agrees that LICENSEE may join RESEARCH FOUNDATION as a party plaintiff in any such suit, without expense to RESEARCH FOUNDATION. The total cost of any such infringement action except as provided in Paragraph 7.4. hereof, commenced or defended solely by LICENSEE shall be borne by LICENSEE and LICENSEE shall keep any recovery or damages for past infringement derived therefrom, provided, that LICENSEE, after deduction of its reasonable costs expended in Pursuit of such infringement, shall remit to Research Foundation a share of said recovery or damages equivalent to a royalty as if such recovery or damages were Net Sales hereunder. If within six (6) months after having been notified of any alleged infringement, LICENSEE shall have been unsuccessful in persuading the alleged infringer to desist and shall not have brought and shall not be diligently prosecuting an infringement action, or if LICENSEE shall notify RESEARCH FOUNDATION at any time prior thereto of its intention not to bring suit against any alleged infringer, then, and in those events only, RESEARCH FOUNDATION shall have the right, but shall not be obligated, to prosecute at its own expense any infringement of the Patent Rights, and RESEARCH FOUNDATION may, for such purposes, use the name of LICENSEE as party plaintiff. No settlement, consent judgment or other voluntary final disposition of the suit may be entered into without the consent of the other party, which consent shall not unreasonably be withheld. In the event that LICENSEE shall undertake the enforcement and/or defense of the Patent Rights by litigation, LICENSEE may withhold up to fifty percent (50%) of the royalties otherwise thereafter due RESEARCH FOUNDATION hereunder and apply the same toward reimbursement of up to fifty percent (50%) of its expenses, including reasonable attorneys fees, in connection therewith. Any recovery by LICENSEE of damages for past infringement in any such suit shall be applied first in satisfaction of any unreimbursed expenses and legal fees of LICENSEE relating to the suit, and next toward reimbursement of RESEARCH FOUNDATION for any royalties past due or withheld and applied pursuant to this Article VII. LICENSEE shall keep the balance remaining from any such recovery subject to the proviso set forth in Article 7.2 above. In the event that a declaratory judgment action alleging invalidity or noninfringement of any of the Patent Rights shall be brought against RESEARCH FOUNDATION, LICENSEE at its option, shall have the right, within thirty (30) days after commencement of such action, to intervene and take over the sole defense of the action at its own expense except as provided in Paragraph 7.4. In any infringement suit as either party may institute to enforce the Patent Rights pursuant to this Agreement, the other party hereto shall, at the request and expense of the party initiating such suit, cooperate in all respects and, to the extent possible, have its employees testify when requested and make available relevant records, papers, information, samples, specimens, and the like. RESEARCH FOUNDATION warrants and represents that it has the lawful right to grant the license provided in this Agreement and that it has not granted rights or licenses in derogation of this Agreement. RESEARCH FOUNDATION agrees that during the term of this Agreement, or any license granted hereunder, RESEARCH FOUNDATION shall not enter into any other agreements that conflict with the rights or obligations provided hereunder, including any rights and obligations that survive termination of this Agreement. ARTICLE VIII. PRODUCT LIABILITY LICENSEE shall, at all times during the term of this Agreement and thereafter, indemnify, defend and hold RESEARCH FOUNDATION, the University and their trustees, officers, employees and affiliates, harmless against all claims and expenses, including legal expenses and reasonable attorneys fees, arising out of the death of or injury to any person or persons or out of any damage to property and against any other claim, proceeding, demand, expense and liability of any kind whatsoever, resulting from the LICENSEEs, LICENSEEs Affiliated Companies, or any of its sublicensees production, manufacture, sale, use (both experimental and consumer), lease, consumption or advertisement of the Licensed Product(s) and/or Licensed Process(es) or arising from any obligation of the LICENSEE hereunder. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS AGREEMENT, RESEARCH FOUNDATION MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND VALIDITY OF PATENT RIGHTS CLAIMS, ISSUED OR PENDING. ARTICLE IX. EXPORT CONTROLS 9.1. It is understood that RESEARCH FOUNDATION is subject to United States laws and regulations controlling the export of technical data, computer software, laboratory prototypes and other commodities (including the Arms Export Control Act, as amended and the Export Administration Act of 1979), and that its obligations hereunder are contingent on compliance with applicable United States export laws and regulations. The transfer of certain technical data and commodities may require a license from the cognizant agency of the United States Government and/or written assurances by LICENSEE that LICENSEE shall not export data or commodities to certain foreign countries without prior approval of such agency. RESEARCH FOUNDATION neither represents that a license shall not be required nor that, if required, it shall be issued. ARTICLE X. NON-USE OF NAMES 10.1. LICENSEE shall not use the names of RESEARCH FOUNDATION, the University of Akron nor of any of its employees, nor any adaptation thereof, in any advertising, promotional or sales literature without prior written consent obtained from RESEARCH FOUNDATION in each case, except that LICENSEE may state that it is licensed by RESEARCH FOUNDATION under one or more of the patents and/or applications comprising the Patent Rights. ARTICLE XI. ASSIGNMENT This Agreement is not assignable except that (i) LICENSEE may assign this Agreement in connection with any merger, consolidation, sale of all or substantially all of its assets or equity, or sale of a controlling interest in LICENSEE, and (ii) LICENSEE may assign this Agreement to another entity in which LICENSEE maintains at least a majority ownership interest. ARTICLE XII. ARBITRATION Any and all claims, disputes or controversies arising under, out of, or in connection with this Agreement, including any dispute relating to patent validity or infringement, which have not been resolved by good faith negotiations between the parties, shall be resolved by final and binding arbitration in Akron, Ohio under the rules of the American Arbitration Association, or the Patent Arbitration Rules if applicable, then obtaining. The arbitrators shall have no power to add to, subtract from or modify any of the terms or conditions of this Agreement. Any award rendered in such arbitration may be enforced by either party in either the courts of the State of Ohio or in the United States District Court for the Northern District of Ohio, to whose jurisdiction for such purposes RESEARCH FOUNDATION and LICENSEE each hereby irrevocably consents and submits. Notwithstanding the foregoing, nothing in this Article shall be construed to waive any rights or timely performance of any obligations existing under this Agreement. ARTICLE XIII. TERMINATION RESEARCH FOUNDATION shall have the right to terminate this Agreement at any time upon notice to LICENSEE in the event either (a) If LICENSEE shall file in any court, pursuant to any statute either of the United States or any state, a petition in bankruptcy or insolvency or for the appointment of a receiver or trustee of all or substantially all of LICENSEE property, or if LICENSEE shall make an assignment for the benefit of creditors, or if LICENSEE shall commit any other affirmative act of insolvency; or (b) if there shall be filed against LICENSEE in any court, pursuant to any statute either of the United States or any state, an involuntary petition in bankruptcy or insolvency or for reorganization, or if there shall be involuntarily appointed a receiver or trustee of all or substantially all of LICENSEEs property, unless such petition or appointment is set aside or withdrawn or ceases to be in effect within one hundred twenty (120) days of the date of the filing or the appointment. Should LICENSEE fail to pay RESEARCH FOUNDATION royalties due and payable hereunder, RESEARCH FOUNDATION shall have the right to terminate this Agreement on thirty (30) days notice, unless LICENSEE shall pay RESEARCH FOUNDATION within the thirty (30) day period, all such royalties and interest due and payable. Upon the expiration of the thirty (30) day period, if LICENSEE shall not have paid all such royalties and interest due and payable, the rights, privileges and license granted hereunder shall terminate. Upon any material breach or default of this Agreement by LICENSEE, other than those occurrences set out in Paragraphs 13.1. and 13.2. hereinabove, which shall always take precedence in that order over any material breach or default referred to in this Paragraph 13.3., RESEARCH FOUNDATION shall have the right to terminate this Agreement and the rights, privileges and license granted hereunder by thirty (30) days notice to LICENSEE. Such termination shall become effective unless LICENSEE shall have cured any such breach or default prior to the expiration of the thirty (30) day period. LICENSEE shall have the right to terminate this Agreement at any time on thirty (30) days notice to RESEARCH FOUNDATION, and upon payment of all amounts due RESEARCH FOUNDATION through the effective date of the termination. Upon termination of this Agreement for any reason, nothing herein shall be construed to release either party from any obligation that matured prior to the effective date of such termination. LICENSEE may, however, after the effective date of such termination, sell all Licensed Products, and complete Licensed Products in the process of manufacture at the time of such termination and sell the same, provided that LICENSEE shall pay to RESEARCH FOUNDATION the royalties thereon as required by Article IV of this Agreement and shall submit the reports required by Article V. hereof on the sales of Licensed Products. ARTICLE XIV. PAYMENTS, NOTICES AND OTHER COMMUNICATIONS 14.1. Any payment, notice or other communication pursuant to this Agreement shall be sufficiently made or given on the date of mailing if sent to such party by Certified First Class Mail, Postage Prepaid, addressed to it at its address below or as it shall designate by written notice given to the other party: In the case of RESEARCH FOUNDATION: In the case of LICENSEE: University of Akron Research Foundation _____________________ Attention: Business Manager _____________________ 170 University Circle _____________________ Akron OH 44325-2103 _____________________ ARTICLE XV. MISCELLANEOUS PROVISIONS This Agreement shall be construed, governed, interpreted and applied in accordance with the laws of the State of Ohio, U.S.A., except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent was granted. The parties hereto acknowledge that this Agreement sets forth the entire Agreement and understanding, and supersedes and makes null and void any and all prior understandings and agreements, of the parties hereto as to the subject matter hereof, and shall not be subject to any change or modification except by the execution of a written instrument subscribed to by the parties hereto. The provisions of this Agreement are severable, and in the event that any provisions of this Agreement shall be determined to be invalid or unenforceable under any controlling body of the law, such invalidity or unenforceability shall not in any way affect the validity or enforceability of the remaining provisions hereof. LICENSEE agrees to mark the Licensed Products sold in the United States with all applicable United States patent numbers. All Licensed Products shipped to or sold in other countries shall be marked in such a manner as to conform to the patent laws and practice of the country of manufacture or sale. The failure of either party to assert a right hereunder or to insist upon compliance with any term or condition of this Agreement shall not constitute a waiver of that right or excuse a similar subsequent failure to perform any such term or condition by the other party. IN WITNESS WHEREOF, the parties have hereunto set their hands and seals and fully executed this Agreement UNIVERSITY OF AKRON LICENSEE RESEARCH FOUNDATION By _____________________________________ By _____________________________________ Name _____________________________________ Name _____________________________________ Title _____________________________________ Title _____________________________________ Date _____________________________________ Date _____________________________________ Acknowledged and Agreed to: ___________________________________________ ___________________________________________ Inventor University of Akron APPENDIX A Patent Applications U.S. Patent No U.S. Patent Application Serial No. U.S. Patent Application Serial No. U.S. Provisional Patent Application Serial No.     PAGE 7  TIME \@ "M/d/yy" 11/4/13 -  PAGE 5 - Xw CEWX}~S T [!n!"&"G#a#b#%&&u,w,0007-7.7;;;KKK,PGPHPSSSXUnUoUVVV[[[fff6iZi[io}qr"r#r7r9rGrHrJrmrprrrh5\^J h^J h5\ hH* h5>*h@h; h5h! hCJhM c d    & F$a$_`|}CDEWX^ & F 80^`0 & F^$$^ & F}~yz'(S T E#F#G#b#c#%%%&&' & F $0^`0a$ 0^`0$^a$^ & F 80^`0^ & F 0^`0' '))0+1+(-)-...0000022445577 & F $a$ & F^^ & F ^`7.7/799;;;;Z<[< @ @bCcCFFHHIIKKK$a$ & F ^`^ & F 80^`0$^a$KKNN*P+P,PHPIPSSSSSWUXUoUpUVVVVV & F 0^`0$^a$ 0^`0$a$^ & F V[Z\Z[[[[_ _ aa^c_c@dAdffffhhh\h]hh ^` 0^`0 & F $^a$^ & F hhi4i5i6i[i\itjujkk=m>mknln{o|o}ooo pppprp^ & F$^a$^ ^`rpsppp$q%q|q}qqqqr"r#r7r8r9rHrIrJrnrorprrrr$a$$a$$^a$^8^8rrrrrrrrrrrrrrrr ssss$a$$a$&`#$^rrrrrrrrrrrrrrrrrrrrrrrrssss s s s ssssƵ hCJh!CJhmHnHujhCJUh hCJhh!CJmHnHu hCJjhCJUh0JmHnHu h0Jjh0JUhR-jhR-U h7h"2 00&P/ =!"#$=% 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH D`D NormalCJOJQJ_HmH sH tH B@B  Heading 1$$@&a$>*CJJ@J  Heading 2$$@&^a$>*CJDA`D Default Paragraph FontViV 0 Table Normal :V 44 la (k ( 0No List 4>@4 Title$a$5CJ2B@2 Body TextCJHC@H Body Text Indent ^CJLR@"L Body Text Indent 2 ^CJ4 @24 Footer  !.)@A. Page Number4R4 Header  !@J@b@ Subtitle$a$5\^JaJZS@rZ Body Text Indent 3$p0^p`0a$CJPK!pO[Content_Types].xmlj0Eжr(΢]yl#!MB;.n̨̽\A1&ҫ QWKvUbOX#&1`RT9<l#$>r `С-;c=1g'}ʅ$I1Ê9cY<;*v7'aE\h>=,*8;*4?±ԉoAߤ>82*<")QHxK |]Zz)ӁMSm@\&>!7;ɱʋ3װ1OC5VD Xa?p S4[NS28;Y[꫙,T1|n;+/ʕj\\,E:! t4.T̡ e1 }; [z^pl@ok0e g@GGHPXNT,مde|*YdT\Y䀰+(T7$ow2缂#G֛ʥ?q NK-/M,WgxFV/FQⷶO&ecx\QLW@H!+{[|{!KAi `cm2iU|Y+ ި [[vxrNE3pmR =Y04,!&0+WC܃@oOS2'Sٮ05$ɤ]pm3Ft GɄ-!y"ӉV . `עv,O.%вKasSƭvMz`3{9+e@eՔLy7W_XtlPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-!pO[Content_Types].xmlPK-!֧6 -_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!!Z!theme/theme/theme1.xmlPK-! ѐ'( theme/theme/_rels/themeManager.xml.relsPK]# k* FFFIrs:E'7KVhrprs;<=>?@ABCD ,48?AI! 4!4uyjjjjjjjjjkkpv^n'-c6i6WWYYYYF[U[arbJjljpjjjjjjjjjjjjjkk::::::::::::::f 47X>ACb}gb !^0 $n=E%žp[/>ܲ3^`>o(.>^`>o(..p0p^p`0o(...@ 0@ ^@ `0o(.... xx^x`o( ..... HH^H`o( ...... `^``o(....... P`P^P``o(........ ^`o(.........hh^h`o(.88^8`o(..p0p^p`0o(...@ 0@ ^@ `0o(.... xx^x`o( ..... HH^H`o( ...... `^``o(....... P`P^P``o(........ ^`o(.........0^`0o(.0^`0o(..p0p^p`0o(...@ 0@ ^@ `0o(.... xx^x`o( ..... HH^H`o( ...... `^``o(....... P`P^P``o(........ ^`o(.........0^`0o(.0^`0o(..p0p^p`0o(...@ 0@ ^@ `0o(.... xx^x`o( ..... HH^H`o( ...... `^``o(....... P`P^P``o(........ ^`o(......... z^`zo(VzV^V`zo(.p0p^p`0o(..@ 0@ ^@ `0o(... xx^x`o( .... HH^H`o( ..... `^``o( ...... P`P^P``o(....... ^`o(........ 0^`0o(.0^`0o(..p0p^p`0o(...@ 0@ ^@ `0o(.... xx^x`o( ..... HH^H`o( ...... `^``o(....... P`P^P``o(........ ^`o(.........hh^h`o(.88^8`o(..p0p^p`0o(...@ 0@ ^@ `0o(.... xx^x`o( ..... HH^H`o( ...... `^``o(....... P`P^P``o(........ ^`o(.........k/w3AC !47+jy#{?@ABCDEFHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijkmnopqrsuvwxyz{~Root Entry FŘ1TableGKHWordDocument4SummaryInformation(lDocumentSummaryInformation8tCompObj` F Microsoft Word 97-2004 DocumentNB6WWord.Document.8